SCHEMBL22448290

SCHEMBL22448290

Nc1cc(NCc2cccc(Cl)c2)cnc1N

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 2/20 0.50
▸ MAP4K4 O95819 1/20 0.49
▸ HDAC3 O15379 1/20 0.47
▸ HDAC1 Q13547 1/20 0.47
▸ HDAC2 Q92769 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ TP53 P04637 1/20 0.47
▸ EGFR P00533 2/20 0.44
▸ CDK1 P06493 1/20 0.44
▸ SRC P12931 1/20 0.44
▸ TMIGD3 P0DMS9 1/20 0.44
▸ HTR2C P28335 1/20 0.44
▸ HTR2B P41595 1/20 0.44
▸ DHFR P00374 1/20 0.44
▸ FYN P06241 1/20 0.44
▸ MAOB P27338 1/20 0.44
▸ HTR6 P50406 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ GRM4 Q14833 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22448311 0.84 DHFR (0.48) APPMAP4K4HDAC3HDAC1HDAC2
SCHEMBL22448315 0.83 DHFR (0.59) APPEGFRDHFRBACE1
SCHEMBL20874965 0.75 APP (0.48) APPMAP4K4HDAC3HDAC1HDAC2
SCHEMBL6700054 0.74 CHRM2 (0.55) APPHDAC3HDAC1HDAC2HDAC6
SCHEMBL632217 0.74 CHRM2 (0.55) APPHDAC3HDAC1HDAC2HDAC6
SCHEMBL21303629 0.74 CDC7 (0.51) APPMAP4K4HDAC3HDAC1HDAC2
SCHEMBL11389411 0.73 HDAC3 (0.49) HDAC3HDAC1HDAC2HDAC6FYN
SCHEMBL22440204 0.73 CDC7 (0.56) HDAC3HDAC1HDAC2HDAC6EGFR
SCHEMBL11510712 0.73 HDAC4 (0.54) HDAC3HDAC1HDAC2HDAC6MAOB
SCHEMBL1196472 0.73 MAOB (0.56) APPHDAC6MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3589632-B1 NOVEL INHIBITORS OF BACTERIAL GLUTAMINYL CYCLASES FOR USE IN THE TREATMENT OF PERIODONTAL AND RELATED DISEASES Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung Ev (DE) 2020-09-23 — — EP disclosed
Send feedback